Get the Stockscreener App
463.64
2.27%
10.30
Medpace Holdings Inc stock is traded at $463.64, with a volume of 328.94K.
It is up +2.27% in the last 24 hours and down -2.95% over the past month.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
See More
Previous Close:
$453.34
Open:
$453.98
24h Volume:
328.94K
Relative Volume:
0.71
Market Cap:
$13.03B
Revenue:
$2.23B
Net Income/Loss:
$418.30M
P/E Ratio:
34.47
EPS:
13.45
Net Cash Flow:
$579.82M
1W Performance:
+1.26%
1M Performance:
-2.95%
6M Performance:
+36.28%
1Y Performance:
+20.01%
1-Day Range:
$453.98
$467.88
1-Week Range:
$452.77
$469.41
52-Week Range:
$250.05
$501.30
Medpace Holdings Inc Stock (MEDP) Company Profile
Name
Medpace Holdings Inc
Sector
Industry
Phone
(513) 579-9911
Address
5375 MEDPACE WAY, CINCINNATI, OH
Compare MEDP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MEDP
Medpace Holdings Inc
|
463.64 | 13.00B | 2.23B | 418.30M | 579.82M | 13.45 |
|
TMO
Thermo Fisher Scientific Inc
|
499.99 | 184.10B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
211.80 | 149.66B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
645.55 | 51.03B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
121.63 | 33.56B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
191.15 | 32.73B | 15.70B | 1.24B | 2.01B | 6.91 |
Medpace Holdings Inc Stock (MEDP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Downgrade | UBS | Neutral → Sell |
| Jul-23-25 | Downgrade | TD Cowen | Hold → Sell |
| Jun-24-25 | Initiated | Barclays | Equal Weight |
| Apr-22-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Apr-14-25 | Downgrade | TD Cowen | Buy → Hold |
| Mar-24-25 | Initiated | Leerink Partners | Market Perform |
| Oct-23-24 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Oct-14-24 | Initiated | Redburn Atlantic | Buy |
| Sep-27-24 | Downgrade | UBS | Buy → Neutral |
| Sep-25-24 | Downgrade | Jefferies | Buy → Hold |
| Aug-01-24 | Initiated | Truist | Hold |
| May-29-24 | Initiated | TD Cowen | Buy |
| May-28-24 | Initiated | Mizuho | Buy |
| Apr-23-24 | Upgrade | Jefferies | Hold → Buy |
| Mar-18-24 | Initiated | Deutsche Bank | Hold |
| Feb-15-24 | Upgrade | UBS | Neutral → Buy |
| Oct-24-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| May-08-23 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-27-22 | Upgrade | UBS | Sell → Neutral |
| Sep-07-22 | Initiated | UBS | Sell |
| May-24-22 | Initiated | Guggenheim | Neutral |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Oct-02-20 | Upgrade | Truist | Hold → Buy |
| Jun-08-20 | Upgrade | Robert W. Baird | Underperform → Neutral |
| May-13-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Apr-30-20 | Upgrade | SunTrust | Sell → Hold |
| Apr-20-20 | Downgrade | Robert W. Baird | Neutral → Underperform |
| Mar-17-20 | Downgrade | SunTrust | Hold → Sell |
| Jan-27-20 | Downgrade | SunTrust | Buy → Hold |
| Oct-31-18 | Upgrade | SunTrust | Hold → Buy |
| Sep-17-18 | Initiated | SunTrust | Hold |
| Jul-31-18 | Upgrade | William Blair | Mkt Perform → Outperform |
| Nov-01-17 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-29-17 | Initiated | Raymond James | Mkt Perform |
| Jul-10-17 | Downgrade | KeyBanc Capital Mkts | Overweight → Sector Weight |
View All
Medpace Holdings Inc Stock (MEDP) Latest News
Clinical Trial Biorepository and Archiving Solutions Market Size Expected to Attain USD 9.69 Billion by 2034 - GlobeNewswire Inc.
Medpace (MEDP) Is Up 5.41% in One Week: What You Should Know - Yahoo Finance
Can Medpace Holdings Inc. scale operations efficientlyQuarterly Earnings Report & Step-by-Step Swing Trade Plans - 선데이타임즈
What makes Medpace Holdings Inc. stock price move sharplyPortfolio Value Report & Weekly High Potential Alerts - thegnnews.com
Multi Factor Analysis Ranks Medpace Holdings Inc. as Strong BuyTrade Volume Summary & Consistent Income Trade Recommendations - sundaytimes.kr
Medpace Volume Surges 63.22% to $240M Ranks 485th in Market Activity as Institutional Capital Flows In - AInvest
Medpace Shares Rally 3.55% on $250M Volume Ranking 406th as Liquidity-Driven Strategy Surpasses Benchmark by 137.53 - AInvest
Earnings Not Telling The Story For Medpace Holdings, Inc. (NASDAQ:MEDP) After Shares Rise 34% - simplywall.st
Medpace slips as UBS cuts to Sell despite strong Q2 results - MSN
Should You Buy Medpace (MEDP) After Golden Cross? - MSN
Can Medpace Holdings Inc. Rally Enough to Break EvenSector Based Breakout Stock Forecast Issued - beatles.ru
Trendline Breach Raises Concern for Medpace Holdings Inc. InvestorsWeekly Hot Picks With Buy Confidence Released - metal.it
Medpace: Return Of The Mack, With Double-Digit Revenue Growth (NASDAQ:MEDP) - Seeking Alpha
Medpace Surprises with Double-Digit Revenue Growth in Q2 2025 - AInvest
Should I hold or sell Medpace Holdings Inc. stock in 2025Free Stock Market Real-Time Monitoring - Jammu Links News
How volatile is Medpace Holdings Inc. stock compared to the marketRapid market gains - Jammu Links News
Published on: 2025-08-04 02:37:58 - Jammu Links News
What catalysts could drive Medpace Holdings Inc. stock higher in 2025Capitalize on momentum-driven opportunities - Jammu Links News
Does Medpace Holdings Inc. stock perform well during market downturnsInvest in stocks with strong fundamentals - Jammu Links News
What drives Medpace Holdings Inc. stock priceDiscover stocks with explosive upside potential - Jammu Links News
Is Medpace Holdings Inc. stock overvalued or undervaluedMarket-leading profit generation - Jammu Links News
What institutional investors are buying Medpace Holdings Inc. stockBuild wealth steadily with smart stock selection - Jammu Links News
Is it the right time to buy Medpace Holdings Inc. stockBuild wealth with professional market analysis - Jammu Links News
Medpace Holdings Inc. Rebound Backed by Sentiment ShiftBuy Signal Based on Chart Analysis Confirmed - beatles.ru
Identifying reversal signals in Medpace Holdings Inc.Real Time Stock Movement Analysis Indicates Breakout - metal.it
How does Medpace Holdings Inc. generate profit in a changing economyDaily Trading Picks With High Returns - Jammu Links News
Have Medpace Holdings Insiders Been Selling Stock? - 富途牛牛
Has Medpace Holdings Inc. Stock Ever Crashed Historical Volatility ReviewChart Driven High Reward Trading Setup Presented - beatles.ru
Medpace Hldgs Insider Sells $21.9M Worth of Stock - AInvest
How Medpace Holdings Inc. stock performs during market volatilityShort Term Buy Zone Stock Alerts Signal Entry - metal.it
Institutional Tools Highlight Unusual Flow in Medpace Holdings Inc.Swing Trading Plan With Smart Signals in Review - metal.it
Medpace general counsel Ewald sells $1.35m in stock - Investing.com
Medpace general counsel Ewald sells $1.35m in stock By Investing.com - Investing.com South Africa
Insider Selling at Medpace Holdings: Distinguishing Routine Moves from Red Flags - AInvest
Medpace stock slips as UBS cuts to Sell (MEDP:NASDAQ) - Seeking Alpha
Why Medpace (MEDP) Stock Is Trading Lower Today - TradingView
MEDP: UBS Downgrades Medpace Holdings, Raises Price Target | MED - GuruFocus
Medpace stock rating downgraded to Sell by UBS on ambitious targets - Investing.com Nigeria
Decoding Insider Selling at Medpace Holdings: A Strategic Investment Analysis - AInvest
North America Clinical Trials Market Forecast and Company Analysis Report 2025-2033 Featuring ICON, Wuxi AppTec, SGS, Syneos Health, PRA Health Sciences, Pfizer, IQVIA, and Medpace - Yahoo Finance
What Makes Medpace (MEDP) a New Strong Buy Stock - sharewise.com
Medpace Holdings Inc Stock (MEDP) Financials Data
Revenue
Net Income
Cash Flow
EPS
Medpace Holdings Inc Stock (MEDP) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| EWALD STEPHEN P | General Counsel & Corp. Secy. |
Jul 28 '25 |
Sale |
450.00 |
3,000 |
1,350,000 |
10,343 |
| BURWIG SUSAN E | Exec. VP, Operations |
Jul 28 '25 |
Sale |
450.14 |
7,500 |
3,376,050 |
57,500 |
| Troendle August J. | CEO |
Jul 28 '25 |
Sale |
451.69 |
48,487 |
21,901,093 |
962,615 |
| GEIGER JESSE J | President |
Jul 24 '25 |
Option Exercise |
107.93 |
41,801 |
4,511,582 |
78,304 |
| GEIGER JESSE J | President |
Jul 24 '25 |
Sale |
453.11 |
41,801 |
18,940,451 |
36,503 |
| Brady Kevin M. | CFO & Treasurer |
Jul 24 '25 |
Option Exercise |
57.94 |
12,000 |
695,280 |
18,000 |
| Brady Kevin M. | CFO & Treasurer |
Jul 24 '25 |
Sale |
454.23 |
12,000 |
5,450,760 |
6,000 |
4.05%
1.90%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):